Eyevensys

Boehringer Ingelheim fuels gene therapy startup focused on eye diseases
Fierce Biotech
Fri, 04/12/13 - 01:49 pm
Boehringer Ingelheim
gene therapy
Eyevensys
Boehringer Ingelheim Venture Fund